معرفی
Serdar Arıcı serves as Associate Professor in the Medical Oncology Department at Istanbul Okan University School of Medicine. His clinical and research focus centers on advanced cancer therapeutics with specialization in gastrointestinal, breast, and lung malignancies.
His educational background includes:
- Medical Degree (2004-2011): Uludağ University Faculty of Medicine
- Specialization in Internal Medicine (2012-2016): Health Sciences University Bursa High Specialization Hospital
- Subspecialization in Oncology (2017-2020): Health Sciences University Istanbul Prof. Dr. Cemil Taşçıoğlu City Hospital
Dr. Arıcı's research spans biomarker validation, treatment response prediction, and novel therapeutic approaches across multiple cancer types. His work particularly emphasizes inflammatory markers (NLR, PLR), molecular profiling (RAS, MSI), and imaging techniques (PET/CT) to optimize treatment selection. Current investigations focus on targeted therapies, immunotherapy combinations, and geriatric oncology applications.
His publication portfolio demonstrates consistent productivity with emphasis on Turkish patient populations, addressing gaps in region-specific oncology data. Key thematic areas include:
- Molecular determinants of treatment response
- Imaging biomarkers for early response assessment
- Age and comorbidity considerations in treatment planning
- Cost-effective diagnostic approaches in resource-constrained settings
Dr. Arıcı actively collaborates with multidisciplinary teams across Turkish oncology centers, with frequent co-authorship alongside researchers including Şener Cihan, Çağlayan Geredeli, and Abdullah SAKİN. His clinical practice integrates translational research findings into personalized treatment protocols.
